Essential thrombocytosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Essential thrombocytosis}} | {{Essential thrombocytosis}} | ||
{{CMG}} | {{CMG}}{{AE}} {{STM}} | ||
==Overview== | ==Overview== | ||
Secondary prevention strategy following Essential thrombocytosis include low dose aspirin in low risk patients. | |||
==Secondary prevention== | |||
*Secondary prevention strategy following Essential thrombocytosis include low dose aspirin in low risk patients. Use of aspirin may help reduce the risk of complications like: | |||
**Stroke | |||
**Myocardial infarction | |||
**TIA | |||
==References== | ==References== |
Revision as of 16:17, 11 November 2015
Essential thrombocytosis Microchapters |
Differentiating Essential thrombocytosis from other Diseases |
---|
Diagnosis |
Treatment |
Essential thrombocytosis secondary prevention On the Web |
American Roentgen Ray Society Images of Essential thrombocytosis secondary prevention |
Risk calculators and risk factors for Essential thrombocytosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Secondary prevention strategy following Essential thrombocytosis include low dose aspirin in low risk patients.
Secondary prevention
- Secondary prevention strategy following Essential thrombocytosis include low dose aspirin in low risk patients. Use of aspirin may help reduce the risk of complications like:
- Stroke
- Myocardial infarction
- TIA